Bacil Pharma

45.67
+2.17
(4.99%)
Market Cap
26.88
Eps
-0.10
PE Ratio (TTM)
73.73
Dividend Yield
0.00
Industry
Healthcare
52 Week High
62.56
52 Week low
7.45
PB Ratio
24.35
Debt to Equity
0.05
Sector
Pharmaceuticals
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
100.00 %
ROE
-47.46 %
ROCE
-47.57 %
EBITDA Margin (Avg.)
-49.54 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
0
0
0
0
0
0
0
0
0
0
1
Expenses
0
0
0
0
0
1
0
4
0
0
0
EBITDA
0
-0
0
0
-0
-0
-0
-4
-0
-0
0
Operating Profit %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
0 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
0
-0
0
-4
-0
-0
-0
-4
-0
-0
0
Tax
0
0
0
0
0
0
0
0
0
0
0
Net Profit
0
-0
0
-4
-0
-0
-0
-4
-0
-0
0
EPS in ₹
-0.05
-0.11
0.00
-6.37
-0.58
-0.54
-0.41
-6.55
-0.17
-0.10
0.60

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
7
7
7
5
5
4
4
1
1
1
Fixed Assets
0
5
6
3
3
3
3
0
0
0
Current Assets
1
0
0
1
1
0
0
0
0
0
Capital Work in Progress
6
0
0
0
0
0
0
0
0
0
Investments
0
0
1
1
1
0
0
0
0
1
Other Assets
1
1
0
1
1
1
1
1
1
1
Total Liabilities
7
7
7
5
5
4
4
1
1
1
Current Liabilities
0
0
0
3
3
3
3
0
0
0
Non Current Liabilities
0
0
0
0
0
0
0
0
0
0
Total Equity
7
6
6
2
2
1
1
1
1
1
Reserve & Surplus
-0
-0
-0
-4
-5
-5
-5
-5
-5
-5
Share Capital
7
7
7
7
7
7
7
7
7
7

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
0
0
0
-0
-0
0
0
-0
0
Investing Activities
-0
-0
0
-1
0
0
1
4
-0
0
Operating Activities
0
0
0
1
-0
-0
-0
-4
-0
0
Financing Activities
0
0
0
0
-0
-0
-0
0
0
-0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
42.67 %
20.70 %
10.60 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
51.38 %
53.85 %
53.88 %
52.88 %
52.83 %
52.90 %
53.74 %
53.77 %
53.76 %
53.79 %
53.80 %
53.77 %
53.89 %
53.91 %
59.61 %
67.42 %
No of Share Holders
0
6,410
6,319
6,461
6,514
6,532
6,545
6,548
6,649
6,663
6,647
6,628
6,770
6,794
6,902
7,461

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,752.75 4,20,543.44 35.94 49,887.20 12.06 9,648 13.77 44.79
6,123.50 1,62,559.68 78.25 8,184.00 0.89 1,600 64.53 60.08
1,436.80 1,16,037.99 23.45 26,520.70 14.17 4,155 47.38 46.67
3,114.70 1,05,415.60 56.43 10,785.70 11.59 1,656 13.54 35.94
2,483.00 1,02,440.36 51.56 10,615.60 19.57 1,942 -16.38 42.73
1,227.55 1,02,428.11 18.95 28,905.40 12.36 5,578 1.69 41.25
2,185.10 99,683.73 36.66 20,141.50 19.94 1,936 73.53 56.12
977.00 98,309.06 22.90 19,831.50 13.82 3,831 29.92 51.89
1,191.75 69,217.03 18.82 29,559.20 17.55 3,169 8.66 48.98
5,117.95 61,192.77 28.08 12,978.40 9.84 1,812 14.16 43.89

Corporate Action

Technical Indicators

RSI(14)
Neutral
45.46
ATR(14)
Volatile
2.84
STOCH(9,6)
Neutral
54.53
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
0.47
ADX(14)
Strong Trend
39.75
UO(9)
Bearish
56.95
ROC(12)
Uptrend But Slowing Down
2.04
WillR(14)
Neutral
-26.82